Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 901 of 1,261

  1. US 8298556

    Methods and related compositions for the non-surgical removal of fat

    The Regents of the University of California · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  2. US 8298532

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  3. US 8299105

    1,2,4-oxadiazole benzoic acid compositions and their use in bioassays

    PTC THERAPEUTICS, INC. · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  4. US 8299261

    1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  5. US 8298606

    Methods and compositions for stabilizing the myocardium

    The Regents of the University of California · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  6. US 8293720

    Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

    Dogwood Pharmaceuticals, Inc. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  7. US 8293275

    Spray freeze dry of compositions for pulmonary administration

    The Regents of the University of Colorado · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  8. US 8293929

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  9. US 8293897

    Compounds comprising a spiro-ring and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  10. US 8293878

    Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  11. US 8293803

    Retinoid compounds and their use

    Reinnervate Limited · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  12. US 8293869

    Polymer conjugates of GLP-1

    Nektar Therapeutics · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  13. US 8293776

    Compositions and methods for treating inflammatory conditions of the bowel

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  14. US 8293272

    Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts

    Globopharm Pharmazeutische Produktions-und Handelsgesellschaft m.b.H. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  15. US 8293800

    Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  16. US 8293901

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  17. US 8293240

    Method of treating drug-resistant cancer

    The Regents of the University of Colorado · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  18. US 8293267

    Method for preparing an antimicrobial cotton of cellulose matrix having chemically and/or physically bonded silver and antimicrobial cotton prepared therefrom

    Biotech, Inc. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  19. US 8293719

    iRNA agents targeting VEGF

    Alnylam Pharmaceuticals, Inc. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  20. US 8293764

    Compositions and methods for disruption of BRCA2-Rad51 interaction

    The Regents of the University of California · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  21. US 8293707

    Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH activity

    Syntonix Pharmaceuticals, Inc. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  22. US 8293724

    Therapeutic applications of fatty acid amide hydrolase inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  23. US 8293729

    Compounds, pharmaceutical composition and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  24. US 8293760

    Cyclopamine lactam analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.